Altajar Sarah, Baffy Gyorgy
Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Department of Medicine, VA Boston Healthcare System, Boston, Massachusetts, USA.
J Clin Transl Hepatol. 2020 Dec 28;8(4):414-423. doi: 10.14218/JCTH.2020.00065. Epub 2020 Oct 15.
The association between the pathogenesis and natural course of nonalcoholic fatty liver disease (NAFLD) and skeletal muscle dysfunction is increasingly recognized. These obesity-associated disorders originate primarily from sustained caloric excess, gradually disrupting cellular and molecular mechanisms of the adipose-muscle-liver axis resulting in end-stage tissue injury exemplified by cirrhosis and sarcopenia. These major clinical phenotypes develop through complex organ-tissue interactions from the earliest stages of NAFLD. While the role of adipose tissue expansion and remodeling is well established in the development of NAFLD, less is known about the specific interplay between skeletal muscle and the liver in this process. Here, the relationship between skeletal muscle and liver in various stages of NAFLD progression is reviewed. Current knowledge of the pathophysiology is summarized with the goal of better understanding the natural history, risk stratification, and management of NAFLD.
非酒精性脂肪性肝病(NAFLD)的发病机制、自然病程与骨骼肌功能障碍之间的关联日益受到认可。这些与肥胖相关的疾病主要源于长期热量过剩,逐渐破坏脂肪-肌肉-肝脏轴的细胞和分子机制,导致以肝硬化和肌肉减少症为代表的终末期组织损伤。这些主要临床表型从NAFLD的最早阶段开始,通过复杂的器官-组织相互作用而发展。虽然脂肪组织扩张和重塑在NAFLD发展中的作用已得到充分证实,但在此过程中骨骼肌与肝脏之间的具体相互作用尚知之甚少。本文综述了NAFLD进展各阶段骨骼肌与肝脏之间的关系。总结了当前病理生理学知识,旨在更好地理解NAFLD的自然病史、风险分层及管理。